ImmPACT Bio Announces FDA Clearance of IND for Novel Bispecific CAR to Treat Aggressive B-cell Lymphoma Read More Feb 3, 2023
Ventyx Biosciences announces pipeline updates and highlights strategic priorities at investor R&D day Read More Jan 23, 2023
NorthSea Therapeutics provides clinical update reflecting progress across NASH and metabolic disorders programmes Read More Jan 5, 2023
Artiva Biotherapeutics Establishes U.S. Research and Manufacturing Facility for NK Cell Therapy Pipeline Development and Clinical Supply Read More Aug 12, 2021